Malin Corporation plc appointed Ian Curley as Chairman, effective immediately, to continue the focus on developing the company’s extensive portfolio of assets and achieving the greatest level of shareholder value in the medium term. The company also appointed Jean-Michel Cosséry and Rudy Mareel as Non-Executive Directors. Each of Owen Hughes, Bob Ingram, Darragh Lyons, who will continue in his current role as Chief Financial Officer, Kieran McGowan and Donal O'Connor, will step down from the Malin board with immediate effect.  Dr. Adrian Howd will continue to serve as Malin's Chief Executive Officer and as a member of the board of directors.  Liam Daniel will continue to serve as Lead Independent Non-Executive Director. Ian Curley has had a long career in business and was most recently the Chief Executive Officer of Ardagh Group S.A. He previously served as Chief Financial Officer of Smurfit Kappa Group plc. Dr. Jean-Michel Cosséry was Vice President, North American Oncology, at Eli Lilly and Company (NYSE listed) and someone with global leadership experience in healthcare. Rudy Mareel is currently CEO of Polyganics and a seasoned executive with in-depth understanding of the global healthcare market.